Basiliximab Vs. rabbit antithymocyte globulin (rATG) induction in "low risk" Kidney transplantation in Colombia

被引：0
作者：
Salcedo, Sergio [1 ]
Giron, Fernando [1 ]
Baez, Yenny [1 ]
Nino-Murcia, Alejandro [1 ]
机构：
[1] Colombiana Trasplantes, Presidencia, Bogota, Colombia
来源：
TRANSPLANTATION | 2016年 / 100卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.1369
引用
收藏
页码：S646 / S647
页数：2
相关论文
共 50 条
[41]   An economic and quality-of-life assessment of basiliximab vs antithymocyte globulin immunoprophylaxis in renal transplantation [J].
Polsky, D ;
Weinfurt, KP ;
Kaplan, B ;
Kim, J ;
Fastenau, J ;
Schulman, KA .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (05) :1028-1033
[42]   Alemtuzumab versus rabbit antithymocyte globulin induction in kidney and pancreas transplantation: A prospective randomized study. [J].
Farney, A. ;
Rogers, J. ;
Ashcroft, E. ;
Hartmann, E. ;
Hart, L. ;
Doares, W. ;
Moore, P. ;
Jarrett, A. ;
Sundberg, A. ;
Adams, P. ;
Stratta, R. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 :233-233
[43]   Assessment of rabbit antithymocyte globulin dosing and clinical outcomes in kidney transplantation [J].
Snyder, Heather ;
Krauss, Amy ;
Rao, Vinaya ;
Ulrich, Dagney ;
Duhart, Benjamin, Jr. .
PHARMACOTHERAPY, 2013, 33 (10) :E241-E241
[44]   Improved safety of basiliximab (Simulect®) over antithymocyte globulin (Thymoglobulin®) induction therapy in heart transplantation [J].
Mattei, M. F. ;
Boissonnat, P. ;
Redonnet, M. ;
Gandjbakhch, I. ;
Bandini, A. Mouly ;
Dorent, R. ;
Yan, C. ;
Blanc, A. S. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02) :S62-S62
[45]   COST-EFFECTIVENESS ANALYSIS OF RABBIT ANTITHYMOCYTE GLOBULIN COMPARED TO BASILIXIMAB IN THE INDUCTION OF RENAL TRANSPLANT PATIENTS [J].
Escudero, P. ;
Misas, J. D. ;
Orozco-Cabal, L. F. .
VALUE IN HEALTH, 2013, 16 (07) :A698-A699
[46]   Highly Sensitized Kidney Recipients (PRA>80%) Benefit from Rabbit Antithymocyte Globulin (rATG) and Rituximab Induction Therapy. [J].
Laftavi, M. R. ;
Seepana, V. ;
Alnimri, M. ;
Patel, S. ;
Kohli, R. ;
Feng, L. ;
Said, M. ;
Pankewycz, O. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 :487-488
[47]   Correction to: Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience [J].
Hong-Feng Huang ;
Jing-Yi Zhou ;
Wen-Qing Xie ;
Jian-Yong Wu ;
Hao Deng ;
Jiang-Hua Chen .
International Urology and Nephrology, 2019, 51 :559-559
[48]   HEALTH ECONOMIC ANALYSIS OF RABBIT ANTITHYMOCYTE GLOBULIN (THYMOGLOBULIN) VERSUS BASILIXIMAB IN RENAL TRANSPLANTATION - A GERMAN PERSPECTIVE [J].
Cremaschi, L. ;
Thaiss, F. ;
Thissen, R. ;
Benzing, T. ;
Milkovich, G. ;
Paivanas, T. ;
Reitan, J. ;
Gallagher, M. ;
Wiesener, M. ;
Zink, N. .
TRANSPLANT INTERNATIONAL, 2015, 28 :57-57
[49]   Nineteen Years Experience with Antithymocyte Globulin Induction in Kidney Pediatric Transplantation [J].
Mota, C. ;
Martins, L. ;
Costa, T. ;
Faria, M. D. S. ;
Henriques, A. Castro .
PEDIATRIC NEPHROLOGY, 2010, 25 (09) :1894-1894
[50]   Combined Induction Therapy with Rabbit Antithymocyte Globulin (rATG) and Rituximab (RTX) in Highly Sensitized Kidney Recipients: Long-Term Outcomes. [J].
Laftavi, M. ;
Patel, S. ;
Kohli, R. ;
Zachariah, M. ;
Feng, L. ;
Said, M. ;
Dayton, M. ;
Pankewycz, O. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 :427-427
12345